Putting the C in CGM: Eversense 365
By Gary Scheiner, MS, CDCES, FADCES
When the first continuous glucose monitors came out, they had short lives and plenty of glitches. In other words, far from continuous. Even today, in 2026, most CGMs have their share of hiccups: warm-up times, transmission lapses, and system errors, just to name a few. From my clinical experience, most users of CGM spend five to ten percent of their time without data, which amounts to one or two hours a day, on average. This is time without the benefit of high/low alerts, numbers of making dosing decisions, trending information, and fuel for driving automated insulin delivery systems.
Then along comes Eversense, the implanted sensor reported to be free of these types of interruptions for a FULL YEAR.
The sensor itself is the size of a thin acetaminophen or ibuprofen caplet. It is placed under the skin by a trained ARNP, physician, or PA who makes a tiny incision, usually on the back of the upper arm, using a special tool developed by the manufacturer (Senseonics). Lidocaine is used to numb the area, so it is a virtually painless procedure. It takes a few days for the incision to heal, which coincides with the initial warm-up time for the sensor.

How the Eversense 365 CGM Works:
In order to send the glucose data from the sensor to a smartphone, a transmitter is placed on the skin using special double-sided tape supplied by Senseonics. The transmitter has a documented range of up to 25 feet. It must be recharged for about 15 minutes every couple of days, and the tape needs to be replaced about as often.
Following the initial 24-hour warmup period for the sensor, the user must perform fingerstick calibrations four times over the next day, and then once per day for the next two weeks. After that, calibrations are required once per week.
Data begins to appear on the Eversense 365 smartphone app soon after the second calibration reading is entered. The app displays the most recent 3 hours of data in the form of a trendgraph along with the current glucose value and a trend arrow. The user may scroll back to see up to 90 days of information. As with other CGM systems, the Eversense 365 app allows event logging and customization of high/low alert thresholds.
Several reports can be generated and shared through the app, and the data syncs with a web-based program called Eversense EMS (there is also a clinic version of this program so that your clinician can see your data).
Statistically Speaking:
Here are some noteworthy numbers regarding Eversense 365 performance, as derived from the company’s pivotal clinical trials.
- Overall MARD (mean absolute relative difference, compared laboratory glucose measurements): 8.8%. The MARD was best in higher glucose ranges, and worst during the first 30 days after sensor insertion.
- Percent of values within 15% of lab values (when glucose is ≥70 mg/dl) and within 15 mg/dl of lab values (when glucose is <70): approx. 85%. This “15/15” measurement tells us when CGM-generated data should lead to similar decisions as the lab-generated glucose value.
- In terms of detecting high and low glucose levels, Eversense detected readings below 70 mg/dl within 15 minutes 97% of the time, but false alerts were generated nearly 50% of the time with the threshold set at 55. Nearly 98% of readings above 180 were detected within 15 minutes with a very low false alert rate in the high range.
- Data availability was excellent through the full year, with readings captured 99.9% of the time (very, very few lost data points). And for the most part, the sensors showed very good durability, with only 10% failing to work for a full year.
My personal experience:
After two months, I can aptly describe my experience as a “Tale of Two Sensors”. The first two weeks were not pleasant. The site where the sensor was inserted itched almost constantly (something that may be unique to me, as most users do not have this problem).
The transmitter kept losing contact with the sensor, and the frequent calibrations, tape changes and transmitter charges were a real pain. And worst of all, the data accuracy was poor. Just about every time I did a fingerstick, the Eversense was at least 20 mg/dl lower.
I was still wearing a Dexcom G7 during this time, and I started to notice that the Eversense took quite a bit longer than the Dexcom to detect both highs and lows. I spoke with some people at Senseonics who informed me that the “lag time” with Eversense is a little longer than with Dexcom or Libre, but this may get better over time.
Patients who have worn Eversense told me the same thing: give it time. So I did. And I’m glad.
After two weeks, about the time the system switched from daily to weekly calibrations, things started to click. The accuracy improved considerably, with absolutely no missed data. The itching stopped. And I learned that daily transmitter charges and tape replacement aren’t really necessary.
From a taping standpoint, I gave up on the double-sided tape that comes with the system and started using cloth-like “Not Just A Patch” overtapes. These patches hold the transmitter securely against my skin and keep their adhesion for several days, even with heavy sweating and hot showers. Now I can go 4-5 days between any kind of system “maintenance”.
A Few of My Favorite Things:
- After the first two weeks or so, the accuracy has been very good… to the point that I trust it to guide my automated insulin delivery system.
- There are virtually no missed data points, except for those occasions when the transmitter has to be removed for charging.
- After the first day, there are no more warm-ups or day-1 accuracy issues like those seen with sensors that must be changed every 10-15 days.
- There is no need to worry about “running out” of sensors or having a sensor “fail”. As stated in the statistical summary, Eversense 365 sensors almost always last the full 365 days.
- The transmitter seems to emit a very strong signal, well beyond the 25 feet stated in the company literature. My phone was picking up the signal in a gym bag while I was at the opposite end of a basketball court.
- There are also no signs of “compression” lows that plague just about every other brand of CGM.

- Since the transmitter needs to be removed to recharge it and apply new tape, there is also a need to place it back on the skin in the exact same location. Luckily, the app includes a “placement guide” that helps you to situate the transmitter in the precise spot. It reminds me of playing the game “Battleship” – as soon as you’re over the correct spot, the radar signal grows so that you can hit the target perfectly. I know, it sounds silly. But it’s kinda fun.
- The weekly calibrations (as well as the daily calibrations during the first two weeks) can be scheduled in the app so that reminders occur at times that are convenient for the user.
- The transmitter has a built-in vibration mechanism to let the user know if trouble is a-brewing (high glucose, low glucose, low battery, etc.), in case you don’t have your phone with you. I have grown to really like this feature. In fact, I’ve turned off all the audible alerts on my phone, so no one around me is disturbed by the alerts.
- Despite some oddly-named and hard-to-locate features, the web-based Eversense DMS software generates some very useful and customizable reports. It contains many of the features I love in reporting software: colorful sensor overlay (spaghetti) graphs, statistical summaries, customizable timeframes, day-of-the-week analyses, long-term trending information, and simple PDF & email generation just to name a few.
Some of my Not-So-Favorite Things:
- Learning the nuances of the system, waiting more than a day for the sensor to generate any data, lots of fingerstick calibrations, and unreliable data make the first couple of weeks rough. In fact, I recommend that anyone who uses an Eversense sensor have another CGM running simultaneously for insulin dosing and other decision-making purposes during at least the first two weeks.
- The sensor insertion (and subsequent removal) is painless, but it is a hassle. It requires a scheduled visit from a trained ARNP, physician, or PA who specializes in performing the procedure and a healing process that takes several days.
- Maintenance is also a hassle. Unlike popular disposable sensors such as Dexcom and Libre, Eversense requires regular tape changes, transmitter charging, and calibration (especially during the first 2 weeks of use).
- Eversense seems to have a longer lag time (the time it takes a change in the blood sugar to be detected and displayed by the sensor) than other CGMs. I’m not the only one to experience this; every other use I’ve spoken to reported similar findings. The added lag time is potentially dangerous. We rely on CGM to warn us of pending highs and lows so that we can take the necessary steps to avoid dangerous extremes. The longer the lag time, the later we are alerted of potential problems.
To verify the longer lag time, I did a little experiment. One day when I had mild hypoglycemia, I treated it with 15g dextrose and checked my blood sugar every 3 minutes with a fingerstick meter (capillary blood sample. I also documented the readings on my Dexcom and on my Eversense apps. Here were the results:

As you can see, both CGMs showed lag time (the fingerstick meter values rose before the CGM values), but the lag time with Eversense was longer than with Dexcom. On average, Dexcom lagged the meter values by about 8 minutes, while Eversense lagged by 12 minutes. Keep in mind that lag times are generally longer than usual when one is recovering from hypoglycemia, but the longer lag time with Eversense is a reason for concern.
- Integration with AID (automated insulin delivery systems) is limited. At the time this article was written, the three most commonly used pump/AID systems are not compatible with Eversense… only the Sequel Twiist, Beta Bionics Mint, and open source platforms such as Loop and Trio.
- The high/low alert options aren’t quite up to speed, at least compared to the latest Dexcom options. There are no “snooze” features or “delay” options for high alerts. And there are no thresholds to establish for rate-of-change alerts. The good news is that Senseonics plans an update to their user interface in the coming months, which will make the alerts more customizable.
- And speaking of high/low alert settings, for some reason, the software engineers designed the system so that you cannot set the alerts within your target glucose range. So if your target range is 70-180, the low alert must be below 70 and the high alert must be above 180. So much for detecting problems before they happen! Users must set an unrealistic target range (100-150, for example) in order to set appropriate alert thresholds.
- The sensor itself has no memory chip, so any time the transmitter is not connected to the sensor (including charging sessions), the data is lost. There is no backfill.

- The home screen on the app, called the “My Glucose” screen, is – for lack of a better term – uninspiring. The target range is difficult to visualize, and including the high/low alert levels on the graph just adds to the clutter. I find the vertical color swaths distracting. Green means the glucose is in the target range. Yellow is in between the target range and the hi/low alert levels, as if anyone cares. And red means you’re either high or low (in other words, “bad”).
It is possible to scroll back as far as you like and see individual data points, but it would be nice if they just kept the home screen simple: show the trend graph with a shaded area for the target range.
We’re all smart enough to know what’s too high and what’s too low without all the extra lines and color designations. As noted above, with an update planned for the user interface, this may become a non-issue. - Interpreting the transmitter’s vibration sequences without looking them up in the user guide isn’t easy. There are six different types of vibration sequences that each mean something different. I think of it like interpreting Morse code. One of my patients compared them to the sounds of the shofar (ram’s horn) on the Jewish high holidays, only without the potential for salvation.
Implant This.
There is no perfect device. No perfect meter. No perfect pump. No perfect insulin pen, infusion set or algorithm. And there is certainly no perfect CGM.
Each one has its share of pros and cons. Eversense 365 meets the needs of those looking for long-term performance, dependability and continuity.
If you’re willing to work through the early learning curve and some of the logistical challenges, you’ll be aptly rewarded.

